Shinji Takai - Search Results

Year	Number of Results
2002	20
2003	16
2004	20
2005	26
2006	25
2007	32
2008	26
2009	25
2010	17
2011	12
2012	13
2013	12
2014	10
2015	7
2016	7
2017	11
2018	9
2019	19
2020	15
2021	18
2022	11
2023	9
2024	4

1

Pathophysiological Role of Chymase-Activated Matrix Metalloproteinase-9.

Takai S, Jin D. Takai S, et al. Biomedicines. 2022 Oct 7;10(10):2499. doi: 10.3390/biomedicines10102499. Biomedicines. 2022. PMID: 36289761 Free PMC article. Review.

2

Targets of chymase inhibitors.

Takai S, Jin D, Miyazaki M. Takai S, et al. Expert Opin Ther Targets. 2011 Apr;15(4):519-27. doi: 10.1517/14728222.2011.555401. Epub 2011 Feb 4. Expert Opin Ther Targets. 2011. PMID: 21291347 Review.

3

Improvement of cardiovascular remodelling by chymase inhibitor.

Takai S, Jin D. Takai S, et al. Clin Exp Pharmacol Physiol. 2016 Apr;43(4):387-93. doi: 10.1111/1440-1681.12549. Clin Exp Pharmacol Physiol. 2016. PMID: 26798995 Review.

4

Chymase Inhibitor as a Novel Therapeutic Agent for Non-alcoholic Steatohepatitis.

Takai S, Jin D. Takai S, et al. Front Pharmacol. 2018 Feb 21;9:144. doi: 10.3389/fphar.2018.00144. eCollection 2018. Front Pharmacol. 2018. PMID: 29515450 Free PMC article. Review.

5

Short review: Geographical distribution of equine-associated pVAPA plasmids in Rhodococcus equi in the world.

Takai S, Suzuki Y, Sasaki Y, Kakuda T, Ribeiro MG, Makrai L, Witkowski L, Cohen N, Sekizaki T. Takai S, et al. Vet Microbiol. 2023 Dec;287:109919. doi: 10.1016/j.vetmic.2023.109919. Epub 2023 Nov 21. Vet Microbiol. 2023. PMID: 38000208 Review.

6

Chymase Inhibition Resolves and Prevents Deep Vein Thrombosis Without Increasing Bleeding Time in the Mouse Model.

Lapointe C, Vincent L, Giguère H, Auger-Messier M, Schwertani A, Jin D, Takai S, Pejler G, Sirois MG, Tinel H, Heitmeier S, D'Orléans-Juste P. Lapointe C, et al. Among authors: takai s. J Am Heart Assoc. 2023 Feb 21;12(4):e028056. doi: 10.1161/JAHA.122.028056. Epub 2023 Feb 8. J Am Heart Assoc. 2023. PMID: 36752268 Free PMC article.

7

Chymase as a Possible Therapeutic Target for Amelioration of Non-Alcoholic Steatohepatitis.

Takai S, Jin D. Takai S, et al. Int J Mol Sci. 2020 Oct 13;21(20):7543. doi: 10.3390/ijms21207543. Int J Mol Sci. 2020. PMID: 33066113 Free PMC article. Review.

8

Downregulation of miR-122-5p Activates Glycolysis via PKM2 in Kupffer Cells of Rat and Mouse Models of Non-Alcoholic Steatohepatitis.

Inomata Y, Oh JW, Taniguchi K, Sugito N, Kawaguchi N, Hirokawa F, Lee SW, Akao Y, Takai S, Kim KP, Uchiyama K. Inomata Y, et al. Among authors: takai s. Int J Mol Sci. 2022 May 7;23(9):5230. doi: 10.3390/ijms23095230. Int J Mol Sci. 2022. PMID: 35563621 Free PMC article.

9

Multiple mechanisms for the action of chymase inhibitors.

Takai S, Jin D, Miyazaki M. Takai S, et al. J Pharmacol Sci. 2012;118(3):311-6. doi: 10.1254/jphs.11r11cp. Epub 2012 Feb 14. J Pharmacol Sci. 2012. PMID: 22333480 Free article. Review.

10

Immunohistological Study of Monkey Foveal Retina.

Ikeda T, Nakamura K, Oku H, Horie T, Kida T, Takai S. Ikeda T, et al. Among authors: takai s. Sci Rep. 2019 Mar 27;9(1):5258. doi: 10.1038/s41598-019-41793-y. Sci Rep. 2019. PMID: 30918305 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

337 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

337 results

Results by year